The Global Compounding Pharmacies Market size was estimated to be US$ 9 billion in 2019 and is expected to grow at a CAGR of 5% through 2030. The compounding pharmacy is an alternative to the mass produced drugs. The patients choose compounding pharmacy when they have been prescribed to a drug containing a substance that they are allergic to. Another occasion of choosing compounding pharmacy includes prescription of a drug that has been discontinued by mass drug producer. The spread of sedentary lifestyle has increased the cases of hormonal imbalance. The compounded hormones have been proved to be effective in treatment of hormonal imbalance. In the United States there are two broad categories of compounding pharmacy, 503A pharmacies can formulate drugs for an individual patient prescription and are regulated by respective states. The other category, 503B outsourcing facilities are capacitated to supply drugs directly to hospitals and clinics and are regulated by both state and the FDA. The compounded drugs produced by clinics and hospitals in large quantities are termed as ‘office stock’. Oral compounded drugs have registered highest demand owing to the ease of ingestion and long shelf life.
Read More@https://www.insightslice.com/compounding-pharmacies-market
